PMVP
PMV Pharmaceuticals, Inc.Company Information
- Company Name
- PMV Pharmaceuticals, Inc.
- CIK
- CIK0001699382
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PMVP: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PMVP
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2025-10-23
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 1,642,876
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 32,015,286
- Shares outstanding
- 53,386,909
- Ownership
- 59.97%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 2.38%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 12 | 39 | 38 | 36 | 44 | 51 | 41 | 49 | 49 | 48 | 38 | 52 | ||||||
| Restricted Cash Current | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 | ||||||
| Marketable Securities Current | 67 | 54 | 75 | 93 | 98 | 109 | 129 | 134 | 164 | 150 | 165 | 150 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 2 | 2 | 3 | 3 | 3 | 6 | 6 | 5 | 4 | 4 | 3 | ||||||
| Assets Current | 81 | 96 | 115 | 132 | 145 | 163 | 176 | 190 | 219 | 202 | 207 | 205 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 11 | 11 | 11 | 11 | ||||||
| Marketable Securities Noncurrent | - | 0 | 0 | 0 | 6 | 5 | 14 | 15 | 0 | 15 | 26 | 36 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 | 8 | 8 | 8 | 9 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 82 | 97 | 117 | 134 | 153 | 171 | 191 | 223 | 238 | 237 | 252 | 261 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 3 | 3 | 3 | 4 | 7 | 2 | 5 | 1 | 3 | 2 | ||||||
| Accrued Liabilities Current | 8 | 7 | 8 | 9 | 9 | 6 | 7 | 10 | 6 | 10 | 10 | 9 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | ||||||
| Liabilities Current | 11 | 9 | 11 | 12 | 12 | 10 | 14 | 14 | 11 | 12 | 14 | 11 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 12 | 12 | 12 | 12 | 13 | ||||||
| Liabilities | 11 | 9 | 12 | 13 | 12 | 11 | 15 | 26 | 23 | 24 | 26 | 23 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital Common Stock | 554 | 552 | 551 | 549 | 548 | 546 | 545 | 543 | 541 | 538 | 535 | 532 | ||||||
| Retained Earnings Accumulated Deficit | -483 | -464 | -446 | -428 | -407 | -386 | -369 | -346 | -326 | -325 | -310 | -294 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | ||||||
| Stockholders Equity | 72 | 88 | 105 | 121 | 141 | 160 | 176 | 198 | 214 | 213 | 226 | 238 | ||||||
| Liabilities And Stockholders Equity | 82 | 97 | 117 | 134 | 153 | 171 | 191 | 223 | 238 | 237 | 252 | 261 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||||||
| Common Stock Shares Issued | 53 | 53 | 53 | 53 | 53 | 52 | 52 | 52 | 52 | 51 | 51 | 51 | ||||||
| Shares Outstanding | 53 | 53 | 53 | 53 | 53 | 52 | 52 | 52 | 52 | 51 | 51 | 51 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPMV Pharmaceuticals, Inc. (PMVP) — SEC Financial Statements & Analysis
PMV Pharmaceuticals, Inc. (PMVP) is a pharmaceutical preparations company, incorporated in DE. PMV Pharmaceuticals, Inc. trades on Nasdaq as: PMVP. PMV Pharmaceuticals, Inc. (PMVP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, PMV Pharmaceuticals, Inc. carries a market cap of $71.54M, a P/E ratio of -0.95x, a P/B ratio of 1.00x, an enterprise value of $59.07M, and an EV/EBITDA multiple of -0.74x. On profitability, it posts a Return on Equity (ROE) of -70.93%, a Return on Assets (ROA) of -64.04%, and a Return on Invested Capital (ROIC) of -102.45%. Per share, it reports EPS of $-1.41, diluted EPS of $-1.41, free cash flow per share of $-1.34, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -6.99% year-over-year and EPS growth of -9.39% year-over-year. On the balance sheet, it maintains a current ratio of 7.70x, a quick ratio of 7.52x, working capital of $70.84M, a debt-to-equity ratio of 0.15x, a debt ratio of 0.13, an interest coverage ratio of -17.78x, free cash flow of $-71.28M (TTM), and net debt of $-12.47M. Figures sourced from SEC EDGAR.
- Market Cap
- $71.54M
- P/E TTM
- -0.95x
- EPS TTM
- $-1.41
- P/B TTM
- 1.00x
- ROE TTM
- -70.93%
- ROA TTM
- -64.04%
- Debt To Equity
- 0.15x
- Free Cash Flow TTM
- $-71.28M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PMV Pharmaceuticals, Inc. in?
PMV Pharmaceuticals, Inc. (PMVP) operates in the Pharmaceutical Preparations industry.
What exchange does PMVP trade on?
PMV Pharmaceuticals, Inc. (PMVP) trades on the Nasdaq.
Where is PMV Pharmaceuticals, Inc. incorporated?
PMV Pharmaceuticals, Inc. is incorporated in DE.
When was PMV Pharmaceuticals, Inc. (PMVP)'s most recent SEC filing?
PMV Pharmaceuticals, Inc. (PMVP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is PMVP's market cap?
PMV Pharmaceuticals, Inc. (PMVP) has a market capitalization of $71.54M as of 2026-06-30.
What is PMVP's EPS (earnings per share)?
PMV Pharmaceuticals, Inc. (PMVP)'s trailing twelve month EPS is $-1.41 as of 2026-06-30.
What is PMVP's ROE (return on equity)?
PMV Pharmaceuticals, Inc. (PMVP)'s trailing twelve month Return on Equity (ROE) is -70.93% as of 2026-06-30.
What is PMVP's ROA (return on assets)?
PMV Pharmaceuticals, Inc. (PMVP)'s trailing twelve month Return on Assets (ROA) is -64.04% as of 2026-06-30.
What is PMVP's ROIC (return on invested capital)?
PMV Pharmaceuticals, Inc. (PMVP)'s trailing twelve month Return on Invested Capital (ROIC) is -102.45% as of 2026-06-30.
What is PMVP's EV/EBITDA?
PMV Pharmaceuticals, Inc. (PMVP)'s trailing twelve month EV/EBITDA is -0.74x as of 2026-06-30.